A detailed history of Charles Schwab Investment Management Inc transactions in Avid Bioservices, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 513,576 shares of CDMO stock, worth $6.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
513,576
Previous 505,252 1.65%
Holding current value
$6.3 Million
Previous $3.61 Million 62.02%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$6.7 - $12.45 $55,770 - $103,633
8,324 Added 1.65%
513,576 $5.84 Million
Q2 2024

Aug 12, 2024

BUY
$6.34 - $9.28 $55,779 - $81,645
8,798 Added 1.77%
505,252 $3.61 Million
Q1 2024

May 08, 2024

BUY
$5.86 - $8.79 $59,332 - $88,998
10,125 Added 2.08%
496,454 $3.33 Million
Q4 2023

Feb 06, 2024

SELL
$4.64 - $9.56 $21,701 - $44,712
-4,677 Reduced 0.95%
486,329 $3.16 Million
Q3 2023

Nov 08, 2023

BUY
$9.4 - $14.04 $117,998 - $176,244
12,553 Added 2.62%
491,006 $4.64 Million
Q2 2023

Aug 09, 2023

BUY
$12.96 - $20.93 $99,973 - $161,454
7,714 Added 1.64%
478,453 $6.68 Million
Q1 2023

May 11, 2023

BUY
$13.48 - $18.79 $62,978 - $87,786
4,672 Added 1.0%
470,739 $8.83 Million
Q4 2022

Feb 13, 2023

BUY
$12.61 - $18.74 $220,195 - $327,237
17,462 Added 3.89%
466,067 $6.42 Million
Q3 2022

Nov 14, 2022

BUY
$15.33 - $20.36 $182,810 - $242,793
11,925 Added 2.73%
448,605 $8.58 Million
Q2 2022

Aug 15, 2022

SELL
$11.63 - $21.55 $73,524 - $136,239
-6,322 Reduced 1.43%
436,680 $6.66 Million
Q1 2022

May 13, 2022

SELL
$16.63 - $27.73 $376,153 - $627,224
-22,619 Reduced 4.86%
443,002 $9.02 Million
Q4 2021

Feb 11, 2022

BUY
$20.7 - $34.18 $204,184 - $337,151
9,864 Added 2.16%
465,621 $13.6 Million
Q3 2021

Nov 16, 2021

BUY
$19.05 - $28.32 $5.86 Million - $8.72 Million
307,747 Added 207.92%
455,757 $9.83 Million
Q2 2021

Aug 16, 2021

SELL
$18.93 - $25.65 $16,469 - $22,315
-870 Reduced 0.58%
148,010 $3.8 Million
Q1 2021

May 17, 2021

BUY
$11.86 - $21.77 $140,813 - $258,475
11,873 Added 8.67%
148,880 $2.72 Million
Q4 2020

Feb 16, 2021

BUY
$7.25 - $11.76 $46,371 - $75,216
6,396 Added 4.9%
137,007 $1.58 Million
Q3 2020

Nov 13, 2020

SELL
$6.53 - $8.6 $34,837 - $45,881
-5,335 Reduced 3.92%
130,611 $996,000
Q2 2020

Aug 14, 2020

BUY
$4.11 - $6.78 $172 - $284
42 Added 0.03%
135,946 $893,000
Q1 2020

May 15, 2020

BUY
$3.15 - $7.39 $11,277 - $26,456
3,580 Added 2.71%
135,904 $695,000
Q4 2019

Feb 07, 2020

SELL
$5.01 - $8.16 $42,134 - $68,625
-8,410 Reduced 5.98%
132,324 $1.02 Million
Q2 2019

Aug 09, 2019

BUY
$3.43 - $5.6 $128,556 - $209,888
37,480 Added 36.3%
140,734 $789,000
Q1 2019

May 14, 2019

SELL
$3.56 - $4.82 $22,235 - $30,105
-6,246 Reduced 5.7%
103,254 $439,000
Q3 2018

Nov 13, 2018

BUY
$4.28 - $7.32 $64,200 - $109,800
15,000 Added 15.87%
109,500 $752,000
Q2 2018

Aug 08, 2018

BUY
$3.1 - $3.93 $292,950 - $371,385
94,500 New
94,500 $371,000

Others Institutions Holding CDMO

About Avid Bioservices, Inc.


  • Ticker CDMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,167,500
  • Market Cap $762M
  • Description
  • Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...
More about CDMO
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.